The KÆRTOR Foundation

The Kærtor Foundation is an initiative of global reach, a pioneer in open innovation and public-private co-development in drug discovery. It provides continuity to the results of the University of Santiago de Compostela (USC) Innopharma project and is led by Professors Mabel Loza, a specialist in Pharmacology, and Ángel Carracedo, a specialist in Genomic Medicine.

A PIONEER RESEARCH INITIATIVE FOR EARLY DRUG DISCOVERY IN COLLABORATION WITH INDUSTRY

Our mission is to promote the reciprocal transfer of knowledge in a circular, translational drug discovery process, generating synergies that increase the value and accelerate the procedure.

THE MAIN AIMS OF THE
KÆRTOR FOUNDATION

WHAT IS REVERSE TRANSFER?

  • The application of transformational science in disease mechanisms to medical and industrial demands
  • Finding the best ideas anywhere in the world and applying them in Galicia with the pharmaceutical companies

News

Kaertor Foundation joins the REMEDI4ALL Funders Network to boost drug repositioning in Europe
9 May, 2025

The Kaertor Foundation has officially joined the Funders Network of REMEDi4ALL, a European initiative funded by the Horizon Europe program that…

Read More
Mabel Loza y Josep Samitier presentaron el Plan Complementario del Programa de Biotecnología Aplicada a la Salud en los Galicia Biodays
13 October, 2022

La Profesora Mabel Loza asistió el pasado 22 de septiembre a las jornadas de “Galicia Biodays”, organizado por Bioga en el Palacio de Exposiciones y Congresos de A Coruña.

Read More
Ángel Carracedo
Ángel Carracedo, catedrático en medicina y presidente de la Fundación Kærtor, reconocido con el Premio Otero Pedrayo 2022
29 September, 2022

Nuestro Presidente, Ángel Carracedo, galardonado con el Premio Otero Pedrayo 2022 por su trayectoria en la investigación médica y científica, que…

Read More